Glen O. Gabbard, M.D., on The Self-Defeating Patient (Open to APA members only.)
L19. Administrative Psychiatry Award LectureArthur L. Lazarus, M.D., M.B.A.,
L20. Seek and Treat for Optimal Prevention of HIV/AIDS STOP HIV/AIDSJulio Montaner, M.D.
Scientific and Clinical Reports
SCR64. Longer Hospitalization Associated With Combinatorial CYP450 Drug Metabolism Deficiencies Gualberto Ruano, M.D.
SCR65. Psychiatric Phenotype in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAs) Andreea Seritan, M.D.
SCR66. Association of Seropositivity for Influenza and Coronaviruses With History of Mood Disorders and Suicide Attempts Olaoluwa Okusaga, M.D.
Session 23. Issues in Child and Adolescent Psychiatry
SCR67. Childhood and Adolescence Predictors of Psychosis in General Population in the Northern Finland 1986 Birth Cohort Pirjo H. Maki, M.D.
SCR68. The Use of Video Feedback to Improve the Mother-Infant Relationship in Women With Postnatal Depression Anne Buist, M.D.
SCR69. Medical Comorbidity in Bipolar Children With Rapid Cycles: Is It Different Relative to Non-Rapid-Cycling Children? Ruby Castilla-Puentes, M.D.
Session 24. Antidepressant Response and Augmentation
SCR70. Quetiapine Augmentation of Antidepressant Treatment in Elderly Depressed Patients Yoram Barak, M.D.
SCR71. Do Adjunctive Stimulants Destabilize Mood in Patients With Bipolar Disorders? Findings From the STEP-BD Joseph Goldberg, M.D.
SCR72. Difference Between Morning and Evening TRH Tests Could Predict Antidepressant Response Fabrice Duval, M.D.
Session 25. (Psycho)pharmacology
SCR73. Tolerability of High-Dose Venlafaxine XL in Depressed Patients Faouzi Alam, M.D.
SCR74. Twelve-Month Herbal Medicine Use for Mental Health From the National Comorbidity Survey: Replication (NCS-R) Simha Ravven, M.D.
SCR75. Relationship Between Serum Venlafaxine, Its Metabolite (O-Desmethylvenlafaxine), and Treatment Response in Patients With Refractory Depression Qaiser Javed, M.B.B.S.
Small Interactive Session
SI20. Alternative Treatments in PsychiatryDavid Mischoulon, M.D.
W102. Fighting Stig ma: When Psychiatrists Who Have Been in Treatment Speak OutCo-Chairs: Michael Myers, M.D., Leah Dickstein, M.D.
W103. Assessment of Capacity: Developments, Documentation, and DefendabilityChair: Michael Wise, M.B.B.S.
MW7. Building Bridges: The Intersection Between Faith and Mental HealthCo-Chairs: Asghar Ali, M.D., Cecil Webster M.D.
S82. Women's Mental Health in Latin America: Present and Future Research
Depression Among Women With Cancer in Ecuador Carlos León Andrade, M.D.
Childhood Sexual and Physical Abuse History in a Gynecology Outpatient Clinic in Colombia: How Abuse Impacts Menopausal Symptoms Ruby C. Castilla Puentes, M.D.
Improving t he Treatment of Depression in Chilean Women Enrique Jadresic, M.D.
Clinical Presentation and Treatment of Girls With Attention-Deficit/Hyperactivity Disorder in Chile and Argentina Arturo P. Grau, M.D.
Women's Mental Health in Latin America: Present and Future Elvia Velásquez, M.D.
Differences and Similarities in Mental Health Issues Between Men and Women in Latin America Jorge Forero, M.D.
Suicidal Behavior and Substance Abuse Among Sexually Abused Girls in Ecuador Emma Saad, M.D.
S83. How Dysfunction of Learning and Memory Circuits Contribute to Substance Abuse and Other Psychiatric DisordersNational Institute on Drug Abuse
Selective Impairments in Reward vs. Punishment Learning in Psychiatric Disorders Mark A. Gluck, Ph.D.
Addiction as Dysfunction in Learning- and Memory-Based Decision Systems: Multiple Potential Failure Points Leading to Multiple Addiction Endophenotypes A. David Redish, Ph.D.
Impaired Modulation of Learned Motivational Responses to Cues: Common Core Dysfunctions in Addiction—and in PTSD Anna Rose Childress, Ph.D.
Neuroplasticity in Prefrontal Regulation of the Basal Ganglia Underlies Vulnerability to Relapse Peter W. Kalivas, Ph.D.
Emotional Influences on Memory Circuits in Posttraumatic Stress Disorder and Healthy Adults Kevin S. LaBar, Ph.D.
S84. Advances in Psychiatric Ethics: New Approaches That Inform Psychiatric Practice
Neuroethics: An Introduction for the Clinical Psychiatrist Jinger G. Hoop, M.D.
Ethical Considerations From Military Psychiatry Christopher H. Warner, M.D.
What Do Forensic Ethics Mean for General Psychiatry? Philip J. Candilis, M.D.
Research Ethics and the Practicing Psychiatrist—The Brave New World of Research in One's Private Practice Donna T. Chen, M.D.
Psychiatric Ethics Through the Prism of Geriatric Research Sahana Misra, M.D.
S86. Autonomy in the Prolongation and Curtailment of Life
The Balance Between Suicide and Autonomous End-of-Life Decisions: A Model Based on Chronic Kidney Disease and Dialysis Lewis M. Cohen, M.D.
Existential Resilience in Metastatic Breast Cancer: Choosing Life While Facing Death David Spiegel, M.D.
Ethics and Judao-Christian Views of Suicide and Life Extension Norman B. Levy, M.D.
Ethics in Suicide Not Associated With Psychiatric Illness James J. Strain, M.D.
S87. New Perspectives on Intergenerational Transmission of BPD
Genetic and Environmental Contributions to Borderline Personality Disorder John Livesley, M.D.
Familial Aggregation and Heritability of Borderline Personality Disorder and Its Component Traits Mary C. Zanarini, Ed.D.
Rejection Sensitivity as a Core Trait of Borderline Personality Disorder Lois W. Choi-Kain, M.D.
Familiality of Candidate Phenotypes John G. Gunderson, M.D.
Infantile Hypersensitivity to the Social Environment and Potential Developmental Failure in Affect Regulation, Effortful Control, and Mentalization Peter Fonagy, Ph.D.
S88. New CANMAT Guidelines for Depression and Bipolar Disorder: Combining Evidence With Clinical Practice
CANMAT Clinical Guidelines for Mood and Anxiety Disorders —History and Development Sidney H. Kennedy, M.D.
CANMAT Clinical Guidelines for Management of Adults With Major Depressive Disorder Raymond W. Lam, M.D.
CANMAT Guidelines for Management of Bipolar Depression Lakshmi N. Yatham, M.B.B.S.
Combining Evidence-Based Psychiatry With Clinical Practice—CANMAT and Other Recent Guidelines Sagar Parikh, M.D.
S89. Psychiatry Across Borders: Working for the U.S. Government in the Department of State as a Psychiatrist
Managing a World of Trouble: Psychiatrists at the State Department 1978-2008 Samuel Thielman, M.A.
Mental Health Response to a Terrorist Attack, Sana'a, Yemen Joseph N. Rawlings, M.D.
Psychiatry Across Borders: Working for the U.S. Government in the Department of State as a Psychiatrist Paul S. Beighley, M.D.
Managing a Psychiatric Medical Evacuation From Overseas Kenneth Dekleva, M.D.
Managing a Psychiatric Medical Evacuation From Overseas Christopher F. Flynn, M.D.
S90. Update on Cannabis Use DisordersNational Institute on Drug Abuse
Marijuana Abuse and Dependence in the General Population: Risk Factors, Symptom Structure, and Axis I and Axis II Comorbidity Effects on Persistence Deborah S. Hasin, Ph.D.
Neurobiology and Brain Imaging of Cannabis Dependence Aviv Weinstein, B.S.C.
Advances in the Development of Behavioral Treatments for Cannabis Use Disorders Alan Budney, Ph.D.
Advances in the Development of Pharmacological Treatments for Cannabis Use Disorders Margaret Haney, Ph.D.
Medical and Psychiatric Effects Associated With Cannabis Use David A. Gorelick, M.D.
S91. Cultural Adaptation of Cognitive-Behavior Therapy for Ethnic and Minority Patients
Implementing CBT for Psychosis in the Treatment of Ethnic Minorities in the United States Michael Garrett, M.D.
Cognitive-Behavior Therapy Across Cultures David G. Kingdon, M.D.
Developing Culturally Sensitive Cognitive-Behavior Therapy for Psychosis: A United Kingdom—Based Study Shanaya Rathod, M.D.
Developing Culturally Sensitive CBT Project Southampton: Adaptation of CBT for Depression in Pakistan Farooq Naeem, M.R.C.
S92. Nonpsychotic Issues of Schizophrenic Patients
Cognitive Rehabilitation of Schizophrenia: Treatment and Research Raquel Gur, M.D.
Smoking and Schizophrenia: Efficacy of New Treatments S. Hossein Fatemi, M.D.
Schizophrenia and Substance Abuse Alan I. Green, M.D.
Approaches to Suicide in Schizophrenia Lawrence Adler, M.D.
S93. Should 'Risk Syndrome of Psychosis' Be Included inDSM-5as a Diagnosis? A Road Toward Preventive Psychiatry
Risk Syndrome of Psychosis as a Diagnosis in DSM-5: Is the Question Legitimate? Amresh Shrivastava, M.D.
The Psychosis Risk Syndrome: On the Right Track but Not Quite There Patrick McGorry, M.D.
An Overview of the Current Status of Risk Syndrome for Psychosis Ming Tsuang, M.D.
Risk Syndrome for Psychosis: A Reliable and Valid Diagnosis Scott Woods, M.D.
Inclusion of the Psychosis At-Risk Category in DSM-5: Is It Premature? Barbara Cornblatt, Ph.D.
S94. Basic Science in Psychiatry: A Move Toward Translational Medicine
Synaptic Biology of Depression: G Proteins, Lipid Rafts, and the Search for a Biomarker Mark Rasenick, Ph.D.
Animal Models: Cell Cycle Regulators and Neurobehavioral Disorders Robert Pechnick, Ph.D.
Altered Brain Bioenergetics: A Reflection of Mitochondrial Dysfunction During the Treatment of Major Depressive Disorder Dan Iosifescu, M.D.
Neurogenesis Assays Prospectively Identify a Novel, Clinically Efficacious Combination for the Treatment of Major Depressive Disorder Carrolee Barlow, M.D.
S95. The Supreme Court and Psychiatry in the 21st Century
A. Atkins v. Virginia: Mental Retardation and the Death Penalty Paul S. Appelbaum, M.D.
B. Clark v. Arizona: The Supreme Court Considers the Insanity Defense and Psychiatric Testimony Steven K. Hoge, M.D.
D. Panetti v. Quarterman (2007) Competence to Be Executed: An Ethical Challenge for Psychiatrists and the Evolution of the Legal Standard Howard V. Zonana, M.D.
E. Indiana v. Edwards: Competence to Represent Oneself Debra Pinals, M.D.
S96. Novel Tools for Preventing and Treating Substance Use and Comorbidities in the Military and Returning VeteransNational Institute on Drug Abuse
Understanding Long-Term Tobacco and Alcohol Use and Comorbid Mental Health Symptoms in Military Service Members and Veterans: The Millennium Cohort Study Tyler C. Smith, Ph.D.
Automated Interactive Voice Response as a Therapeutic Tool for Chronic Pain Reduction and Opioid Medication Use Decrease Magdalena R. Naylor, M.D.
Virtual Reality and D-Cycloserine for Exposure-Based Therapy Barbara Rothbaum, Ph.D.
The Video Doctor Approach: Potential Applications to Psychiatric Practices Serving Patients Impacted By War Barbara Gerbert, Ph.D.
Computer-Based Training in Cognitive-Behavioral Therapy: New Findings and Applications for Military Personnel Kathleen M. Carroll, Ph.D.
AM06. Update on Gastroenterology and Hepatology for Psychiatrists and Mental Health PractitionersNathaniel S. Winstead, M.D.
L21. Seek and Treat for Optimal Prevention of HIV/AIDS: STOP HIV/AIDSJulio Montaner, M.D., Frontiers of Science Lecture
Scientific and Clinical Reports
SCR76. Catatonia: A "Frozen Condition"? New Treatment Options Based on Case Reports and Literature Review Cristinel Coconcea, M.D.
SCR77. Racial Differences in Major Depressive Disorder With Psychotic Features Karen Bullock, Ph.D.
SCR78. Toward a Better Understanding of the Interaction Between Religious Delusions and the Clinical and Religious Background of Patients With Schizophrenia Philippe Huguelet, M.D.
Session 27. Issues in Mood Disorders
SCR79. Minor Mixed Depression, Formerly Mixed Affective State: A Treatable Condition in Violent, Court-Ordered Detention Patients With a Personality Disorder Carel De Blécourt, M.D.
SCR80. Psychosocial Impairment Associated With Dysthymic Disorder in the NESARC Study David Hellerstein, M.D.
SCR81. Increased Mortality and Hospital Readmissions in Patients Depressed at the Time of Discharge From Medical Wards Antonio Campayo, M.D.
Session 28. Epidemiology, Sleep, and Medical Screening
SCR82. Laboratory Evaluation of Psychiatric Patients in the Emergency Room Leslie Zun, M.D.
SCR83. STOP-BANG Sleep Apnea Screening Evinces a High Risk Among Patients Admitted to Psychiatric Units Sam Al-Saadi, M.D., M.S.
SCR84. Schizotypal Personality Disorder in the United States: Prevalence and Correlates in a Representative General Population Sample Vanessa Lentz, M.S.
Session 29. Important but Infrequently Addressed Topics
SCR85. Overdiagnosis of Bipolar Disorder and Disability Payments Mark Zimmerman, M.D.
SCR86. The Economic Impact of Medication-Access Problems Among Medicaid Psychiatric Patients in 10 States Joyce West, Ph.D., M.P.P.
SCR87. Can We Talk? Do Psychotherapists and Prescribing Psychiatrists Communicate With Each Other About Their Mutual Patients? Thomas Kalman, M.D., M.S.
Small Interactive Sessions
SI21. Marc E. Agronin, M.D., on Borderline Personality Spectrum Disorders
SI22. Deborah Spitz, M.D., on Balancing Work and Family (Open to APA resident members only.)
SI23. Ranga Krishnan, M.D., on How to Research Clinical Questions
W106. Making Your Presentation More Interactive: The Better Way!Chair: Jon Davine, M.D.
W107. Games People Play: What Every Psychiatrist Needs to Know About Video GamesCo-Chairs: Deidre Williams, M.D., Faye Chao, M.D.
W108. How to Implement Cardio-metabolic Monitoring Across Large Public Health SystemsCo-Chairs: Laura Kent M.D., Christina Mangurian, M.D.
W112. Feedback on Criteria and Terminology inDSM-5 Co-Chairs: David Kupfer, M.D., Darrel A. Regier, M.D.
MW8. Rachel Is Getting Married, Kym Is Getting Sober, Everyone Is Losing ItAmerican Academy of Addiction Psychiatry Chair: Petros Levounis, M.D.
S97. Hot Topics in Afro-American Mental Health; Impact of Past and Current Prejudices; Womens' Mental Health; HIV; Unique Psychopharmacological Findings
History of Racism in Mental Health: Seeds of Distrust Harriet A. Washington, B.S.
Pseudoscientific Literature Promotes Racial Prejudice Among Physicians Zack Z. Cernovsky, Ph.D.
Black Women and Depression: The Role of Stigma as a Barrier to Treatment Janet E. Taylor, M.D.
HIV and Afro-American Mental Health David W. Smith, M.D.
Response and Tolerability of Psychotropics in African Americans William B. Lawson, M.D.
S98. Dysfunctions in Mentalization or Metacognition in Personality Disorders: Empirical Evidence and Implications for Pathology, Treatment, and Research
Impaired Metacognition and Correlations With Symptoms, Social Functioning, and Overall Personality Disorder Severity Giuseppe Nicolo, M.D.
Improving Mentalization in Borderline Patients in Transference-Focused Psychotherapy (TFP) John Clarkin, Ph.D.
Verbal Elaboration of Distinct Affect Categories in Borderline Personality Disorder Serge Lecours, Ph.D.
S99. Understanding Comorbidity of Heart Disease With Depression and Anxiety Disorders
Depression-Anxiety Comorbidity: Clinical Aspects Jose Luis Ayuso, M.D.
Treatment of Anxiety Disorders Is Associated With a Significantly Lower Prevalence of Secondary Depression Leo Russo, Ph.D.
Neurobiological Mechanisms in Anxiety/Depression and the Impact on Coronary Heart Disease Jorge Tellez-Vargas, M.D.
Understanding Comorbidity of Heart Disease With Depression and Anxiety Disorders Ricardo Secin, M.D.
Depression and Panic Disorders Significantly Increase the Risk for Heart Disease: One More Piece of Evidence Ruby C. Castilla-Puentes, M.D.
Association Study Between Blood Pressure and Personality, Anxiety, and Depression Jorge Ospina, M.D.
Strategies for Optimizing Treatment of Depression and Panic Disorder: What to Do When SSRIs Fail? Carolina Remedi, M.D.
S100. Treating Borderline Personality Disorder: Current Psychodynamic Perspectives
Key Clinical Interventions of Mentalization-Based Treatment Anthony W. Bateman, M.D.
Transference-Focused Psychotherapy in Theory and in Practice Frank E. Yeomans, M.D.
Overview of Expressive Supportive Psychotherapy (ESP) John G. Gunderson, M.D.
An Overview of Integrated Psychotherapy for BPD Glen O. Gabbard, M.D.
Discussion Peter Fonagy, Ph.D.
S101. Comprehensive HIV Psychiatry Update
HIV/AIDS Medical Update David Mushatt, M.D.
Neuropsychiatric Overview Mordecai Potash, M.D.
Neurocognitive Decline Karl Goodkin, M.D.
Psychopharmacology Francisco Fernandez, M.D.
S103. The Ethics of Innovative Interventions in Psychiatry
Ethical Issues in DBS Research for Psychiatric Disorders Laura B. Dunn, M.D.
The Ethics of Genetic Screening for Psychiatric Disorders Paul S. Appelbaum, M.D.
Ethical Issues Related to the Use of Transcranial Magnetic Stimulation and Vagus Nerve Stimulation in Psychiatry Paul Holtzheimer, M.D.
Ethical Issues in Pharmacologic Enhancement Jinger G. Hoop, M.D.